Type 2 Diabetes

Data from an analysis of nearly 400k older patients suggests Medicare Advantage beneficiaries were less likely than their counterparts with commercial insurance to be prescribed newer glucose-lowering agents such as GLP-1RAs and SGLT2 inhibitors.

A trial from LSU's Pennington Biomedical Research Lab indicates a health coach-led intervention in primary care settings was associated with improvements in fasting blood glucose and HDL-C cholesterol.

An intervention implementing the use of a health coach in a primary care setting based on the 2013 AHA/ACC/Task Force for the Management of Overweight and Obesity in Adults guidelines was associated with greater weight loss and improvements in blood glucose levels and HDL-C compared to usual care.

A randomized, cross-over trial of more than 60 overweight individuals indicates a low-fat vegan diet was more effective than a Mediterranean diet for inducing weight loss and lowering cholesterol levels.

An analysis of the ARIC study suggests older patients with prediabetes were more likely to regress to normoglycemia than progress to diabetes during the follow-up period.

More than 25% of adults in the US older than 65 have diabetes.

An analysis of nearly 30k patients from the LEAD study suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.

An analysis of 5-year outcomes data from the Teen-LABS study indicates bariatric surgery was in teens 13-15 years old resulted in similar outcomes as surgery among those 16-19 years old.

An analysis of 29k patients with type 2 diabetes suggests increased HbA1c variability within the first 2 years of a diabetes diagnosis was associated with a 30-59% increase in risk of incident cardiovascular disease.

An analysis of claims data from more than 2k patients with type 2 diabetes provides insight into the effects of initiating use of a flash CGM system on acute diabetes-related events and hospitalizations in CGM-naive patients.

An analysis of data obtained from the CARDIA study offers insight into the subsequent cardiovascular risks associated with gestational diabetes and how glucose control after pregnancy impacts this apparent increase risk.

The rates of preterm delivery and large for gestational age birthweight were higher among women with type 1 diabetes.

An analysis of more than 380k older adults with type 2 diabetes suggests Medicare Advantage Beneficiaries were less likely to initiate therapy with newer glucose-lowering agents, including GLP-1RAs, SGLT2 inhibitors, and DPP-4 inhibitors than their counterparts with commercial insurance.

Women with a history of GD had a 2-fold higher risk of CAC across all subsequent levels of glucose tolerance.

New research from Kaiser Permanente Northern California suggests gestational diabetes was linked to a 2-fold increase in risk of coronary artery calcification, regardless of glycemic control after giving birth.

An analysis of data from more than 40k women details how the use of metformin is associated with increased or decreased risk of certain types of breast cancer.

Low and moderate dosing shows the most potential in preventing AMD for patients with diabetes.

A retrospective analysis of EHR data from 3 Mayo Clinic facilities details prescribing practices for pain medications among patients with newly diagnosed diabetic peripheral neuropathy.

Parents who knew their children were at higher risk of type 1 diabetes were able to get the condition diagnosed before serious complications developed.

Check out our latest emergency department case report from Dr. Brady Pregerson. Can you determine the correct diagnosis?

A secondary analysis of the iDCL suggests use of closed loop insulin therapy was associated with improvements in glucose control among patients with type 1 diabetes.

A study from the University of Chicago Medical Center breaks down the potential for reducing the risk of age-related macular degeneration through use of metformin.

Few diabetic patients adhere to daily blood glucose monitoring, foot checks, eye examinations, and cholesterol checks.

The University of Chicago hypertension expert discusses new ADA recommendations for cardiovascular risk management.